A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
Clinical trial NCT03395080 · COMPLETED
Trial details
- NCT number
- NCT03395080
- Sponsor
- Leap Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2020-09-09
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.